Atenolol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00335 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 17 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | posterolateral myocardial infarction | KG + DL |
| 2 | posteroinferior myocardial infarction | KG + DL |
| 3 | malignant renovascular hypertension | KG + DL |
| 4 | malignant hypertensive renal disease | KG + DL |
| 5 | pulmonary hypertension with unclear multifactorial mechanism | KG + DL |
| 6 | pulmonary hypertension owing to lung disease and/or hypoxia | KG + DL |
| 7 | septal myocardial infarction | KG + DL |
| 8 | Braddock syndrome | KG + DL |
| 9 | chronic pulmonary heart disease | KG + DL |
| 10 | primary hereditary glaucoma | KG + DL |
| 11 | Prinzmetal angina | KG + DL |
| 12 | open-angle glaucoma | KG + DL |
| 13 | coronary stenosis | KG + DL |
| 14 | congenital coronary artery anomaly | KG + DL |
| 15 | congenital tricuspid malformation | KG + DL |
| 16 | scapuloperoneal myopathy | KG + DL |
| 17 | glaucoma 1, open angle | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.